NeoGenomics, Inc. Business Acquisition, Pro Forma Revenue
NeoGenomics, Inc. (NEO) reported Business Acquisition, Pro Forma Revenue of $23.41 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2015-11-06
- NeoGenomics, Inc. business acquisition, pro forma revenue for the quarter ending 2014-09-30 was $23.41M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 9 month |
|---|---|---|
| 2014-09-30 | $23.41M 10-Q · filed 2015-11-06 | $67.29M 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |